These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6542303)

  • 1. [A case of giant prostate cancer].
    Fujimoto Y; Yamaha M; Maeda S; Takeuchi T; Ito Y; Kuriyama M; Ban Y; Nishiura T
    Hinyokika Kiyo; 1984 Jul; 30(7):925-30. PubMed ID: 6542303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of prostate cancer treated with combined androgen-blockade].
    Kurita M; Kato Y; Tamura Y; Suzuki K; Yamanaka H
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):307-10. PubMed ID: 10700907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer.
    Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T
    Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
    Uekado Y
    Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal treatment of carcinoma of the prostate].
    Obata K; Kobayashi H; Murase T; Ohisi M
    Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of prostate cancer resistant to endocrine therapy successfully treated with intra-arterial chemotherapy].
    Mima H; Asano M; Ozeki S; Ehara H; Takahashi Y; Ishihara S; Deguchi T; Kuriyama M; Ban Y; Kawada Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1694-6. PubMed ID: 7574795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy].
    Tsukamoto T; Fukui I; Kihara K; Goto S; Kitahara S; Kobayashi T; Kojima S; Oshima H
    Hinyokika Kiyo; 1996 May; 42(5):351-6. PubMed ID: 8752537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
    Uekado Y; Hirano A; Inagaki T; Hiroi A; Watanabe T
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced prostatic cancer presenting as inguinal mass].
    Ikeda K; Niwa N; Oka F; Ito H; Abe H; Nakagami Y
    Hinyokika Kiyo; 1991 Jul; 37(7):765-7. PubMed ID: 1927782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum].
    Okumura S; Hasegawa J; Ohhara M; Kawamura N; Abe H; Yui Y; Kanamori S; Yoshida K; Nishimura T; Tomita M
    Hinyokika Kiyo; 1984 Dec; 30(12):1801-7. PubMed ID: 6543417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Papillary adenocarcinoma of the prostate with good response to antiandrogen therapy and delayed radiotherapy: a case report].
    Ishizu K; Konishi M; Joko K; Takihara H; Sakatoku J; Tanaka K
    Hinyokika Kiyo; 1992 Mar; 38(3):343-6. PubMed ID: 1381864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
    Iwasawa T; Matsumoto H
    Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful combined treatment with maximal androgen blockade (MAB), intra arterial chemotherapy and radiation for advanced prostatic ductal adenocarcinoma : report of two cases].
    Nishihara C; Kuratsukuri K; Tanaka T; Kawashima H; Nakatani T
    Hinyokika Kiyo; 2011 Apr; 57(4):209-12. PubMed ID: 21646853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo.
    Brisset JM; Boccon-Gibod L; Botto H; Camey M; Cariou G; Duclos JM; Duval F; Gontiès D; Jorest R; Lamy L
    Prog Clin Biol Res; 1987; 243A():411-22. PubMed ID: 3309973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.